Stock Groups

U.S. jury reaches verdict in Theranos trial, to be read soon -Breaking

by Mike Robinson

[ad_1]

© Reuters. Elizabeth Holmes, founder of Theranos, and her family travel to San Jose to see her fraud trial. This is in California on January 3, 2022. REUTERS/Brittany Hosea-Small

Jane Lanhee Lee

SAN JOSE CA (Reuters) – The U.S. jury for Elizabeth Holmes, founder of Theranos, declared Monday that it had reached a unanimous decision. It will be read soon.

Holmes (37), was accused of defrauding private investors in 2010-2015 by convincing them that Theranos small machines could perform a variety of tests using a few drops from their finger.

Holmes was also accused for misleading patients concerning the test’s accuracy.

After founding Theranos, Holmes was a Silicon Valley celebrity.

After meeting the founder, Rupert Murdoch, a media mogul and wealthy private investor invested in millions of dollars.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]